Eli Lilly has launched new single-dose 2.5mg and 5.0mg vials of its obesity drug Zepbound in a move that ... via the company's LillyDirect direct-to-consumer self-pay channel – are "at least ...

Telehealth company Ro will offer single-dose vials ... to Lilly's recently launched LillyDirect direct-to-consumer (DTC) platform that will be able to offer the lower-cost version of Zepbound ...

Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q4 2024 Earnings Call ... the uptake of single-uses Zepbound vials increased. We had no wholesaler backorders as we ...

In contrast to regular direct-to-consumer ... And in the case of Zepbound, patients can purchase the drug directly from the manufacturer, Eli Lilly, at a price that is well below the list price.

“I am against any of this,” she said, citing dangers if pens or vials are used against ... GLP-1s are the requests by Lilly and Novo Nordisk, to put Zepbound and Wegovy on its “Demonstrably ...

Eli Lilly & Co. said Thursday that its Type 2 diabetes drug Mounjaro and its weight-loss and diabetes drug Zepbound drove a 45% increase in fourth-quarter revenue to $13.53 billion. The drugmaker ...

(Reuters) - Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales of popular weight-loss drug Zepbound after it last month ...

STORY: Shares of Eli Lilly jumped Thursday morning after the company, known for its popular weight-loss drug Zepbound, forecast annual profit largely above Wall Street estimates. The outlook ...

On the topic of manufacturing, Lilly has spent the past few years laying out billions of dollars to grow production capacity for Mounjaro and Zepbound. Despite the formal conclusion of Lilly’s ...

Diabetes drug Mounjaro and weight-loss/diabetes medicine Zepbound drove a big revenue increase Eli Lilly & Co. said its Type-2 Diabetes drug Mounjaro and weight-loss/diabetes medicine Zepbound ...